Organovo Holdings, Inc. (NASDAQ:ONVO – Get Rating) saw a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 291,600 shares, a decline of 11.1% from the February 13th total of 327,900 shares. Based on an average daily volume of 111,700 shares, the short-interest ratio is presently 2.6 days.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on Organovo in a research report on Monday. They set a “sell” rating on the stock.
Organovo Stock Down 2.1 %
Shares of Organovo stock opened at $1.83 on Monday. The stock’s fifty day moving average is $1.98 and its 200-day moving average is $1.89. The firm has a market capitalization of $15.94 million, a PE ratio of -1.34 and a beta of 0.89. Organovo has a 12-month low of $1.37 and a 12-month high of $4.11.
Institutional Inflows and Outflows
Organovo Holdings, Inc is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
- Get a free copy of the StockNews.com research report on Organovo (ONVO)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.